Breast Cancer Connect
  • Saved

1yr
The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer - PubMed

The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/39006029/

Advances in understanding the pathological mechanisms of breast cancer have resulted in the emergence of novel therapeutic strategies. However, triple-negative breast cancer (TNBC), a molecular subtype of breast cancer with...

Advances in TNBC treatment highlight CD8+ TRM cells' crucial role in tumor immunity, offering new insights into immunotherapy and targeting strategies for non-luminal breast cancer.

  • Saved

1yr
Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs - PubMed

Opportunities and Challenges in the Development of Antibody-Drug Conjugate for Triple-Negative Breast Cancer: The Diverse Choices and Changing Needs - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/38993251/

Triple-negative breast cancer (TNBC) is a highly heterogeneous breast cancer subtype, which is also characterized by the aggressive phenotype, high recurrence rate, and poor prognosis. Antibody-drug conjugate (ADC) is a...

This review highlights the advancements in antibody-drug conjugates (ADCs) for treating triple-negative breast cancer (TNBC), focusing on sacituzumab govitecan's FDA approval, clinical trials, and future research.

  • Saved

1yr
Breast Cancer: Extracellular Matrix and Microbiome Interactions

Breast Cancer: Extracellular Matrix and Microbiome Interactions

Source : https://pubmed.ncbi.nlm.nih.gov/39000333/

Breast cancer represents the most prevalent form of cancer and the leading cause of cancer-related mortality among females worldwide. It has been reported that several risk factors contribute to the...

Understanding the interplay between the extracellular matrix and microbiome in breast cancer may reveal innovative treatment strategies and improve patient outcomes by targeting these emerging therapeutic avenues.

  • Saved

1yr
Immunotherapy in Breast Cancer

Immunotherapy in Breast Cancer

Source : https://pubmed.ncbi.nlm.nih.gov/39062758/

Breast cancer is a disease encompassing a spectrum of molecular subtypes and clinical presentations, each with distinct prognostic implications and treatment responses. Breast cancer has traditionally been considered an immunologically...

In summary, immunotherapy, particularly checkpoint inhibitors, is advancing the treatment of breast cancer, with promising clinical trials and biomarkers paving the way for personalized and effective therapies.

  • Saved

1yr

Did you know? The introduction of HPV vaccines has led to a dramatic reduction in cervical cancer rates, decreasing by 87% among women aged 20-24 who were vaccinated as preteens. These vaccines not only protect against cancer but also prevent other HPV-related conditions, marking a significant advancement in women’s health.

Could expanding HPV vaccination to broader age groups further reduce the global burden of cervical cancer?

background

Could expanding HPV vaccination to broader age groups further reduce the global burden of cervical cancer?